Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc (GSK) covers the period ending November 19, 2002. The report details a specific corporate action regarding the repurchase of ordinary shares, executed in accordance with shareholder authority granted at the Annual General Meeting on May 20, 2002.
Key Financial Metrics
The filing does not provide comprehensive financial statements, revenue, profit, cash flow, margins, debt, or liquidity metrics. The only financial data disclosed relates to the share repurchase transaction:
- Shares Purchased: 800,000 ordinary shares
- Price per Share: 1,228.7008 pence
- Transaction Purpose: Purchase for cancellation
Material Changes
The filing reports a reduction in the company's outstanding share count due to the cancellation of 800,000 shares. No other material changes to operations, financial position, or results of operations are disclosed in this specific document.
Guidance, Outlook, and Risks
The filing contains no management commentary, forward-looking guidance, risk factors, contingencies, or discussion of unusual items beyond the execution of the authorized share buyback.
Investor Verification Points
- Verify the total number of shares authorized for repurchase at the May 20, 2002 Annual General Meeting to determine remaining buyback capacity.
- Confirm the total capital outflow for this specific transaction (800,000 shares x 1,228.7008p).
- Review subsequent filings for the impact of this share cancellation on earnings per share (EPS) and total equity.